Verona Pharma PLC Holding(s) in Company (1047G)
August 03 2016 - 3:37AM
UK Regulatory
TIDMVRP
RNS Number : 1047G
Verona Pharma PLC
03 August 2016
i
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or
the underlying issuer of existing
shares to which voting rights Verona Pharma plc
are attached: ii
------------------------------------------------------------- -------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------- -----------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------- -----------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------- -----------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------- -----------------------------------
Other (please specify):
--------------------------------------------------------------- -----------------------------------
3. Full name of person(s)
subject to the notification Vivo Ventures VII, LLC
obligation: iii
----------------------------------------------------------- ---------------------------------------
4. Full name of shareholder(s) Vivo Ventures fund VII, LP
(if different from 3.):iv Vivo Ventures VII Affiliates
Fund, LP
----------------------------------------------------------- ---------------------------------------
5. Date of the transaction
and date on which the threshold July 29, 2016
is crossed or
reached: v
----------------------------------------------------------- ---------------------------------------
6. Date on which issuer notified: July 29, 2016
----------------------------------------------------------- ---------------------------------------
7. Threshold(s) that is/are
crossed or reached: vi, vii 6.5% to 9.84% Change at Combined
Interest Level
----------------------------------------------------------- ---------------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares viii, ix
---------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of shares to the triggering triggering transaction
transaction
if possible
using the
ISIN CODE
---------------- ---------------------------- ---------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights x
Shares Voting
Rights
---------------- ------------- ------------- -------------- ----------------------- ----------------------
Direct
Direct xi Indirect Direct Indirect
xii
---------------- ------------- ------------- -------------- ------- -------------- --------- -----------
GB00B06GSH43 65,600,000 65,600,000 252,393,874 252,393,874 9.84%
---------------- ------------- ------------- -------------- ------- -------------- --------- -----------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Conversion Number of voting % of voting
instrument date xiii Period xiv rights that rights
may be
acquired if
the instrument
is
exercised/ converted.
------------------ ----------- --------------------- ----------------------- ------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
xv, xvi
---------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date xvii Conversion rights instrument rights xix,
period refers to xx
xviii
------------------ --------- ----------- ------------ ------------------- --------------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- ---------- --------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
252,393,874 9.84%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if
applicable: xxi
Vivo Ventures VII, LLC is the general partner of both Vivo
Ventures Fund VII, LP (VV Fund VII) and Vivo Ventures VII
Affiliates Fund, LP. (Affiliates Fund VII). Accordingly, Vivo
Ventures VII, LLC may be deemed to have indirect beneficial
ownership of shares of the Issuer directly owned by VV Fund VII and
Affiliates Fund VII. As of the date of this filing, VV Fund VII and
Affiliates Fund VII beneficially own 247,010,316 and 5,383,558
shares of Common Stock respectively.
Proxy Voting:
----------------------------------------
10. Name of the proxy holder:
--------------------------------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------------------
13. Additional information:
--------------------------------- --------------------------------
Vivo Capital, LLC Attn: Cinthia
14. Contact name: Sheu
--------------------------------- --------------------------------
15. Contact telephone number: +1-650-688-0818
--------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGURPRUPQUMW
(END) Dow Jones Newswires
August 03, 2016 03:37 ET (07:37 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
